| 摘要 |
The present disclosure relates to high protein dietary supplements for treating various symptoms and diseases associated with protein deficiency including weight gain, obesity, catabolic diseases, fibromyalgia, anxiety reactions, posttraumatic stress and chronic fatigue syndrome. Embodiments of dietary supplements comprise combinations of proteins, essential and semi-essential amino acids including L-Lysine, L-Arginine, and/or L-Histidine. |
| 主权项 |
1. A dietary supplement comprising free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan, wherein the free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan are the only free-form amino acids in the dietary supplement and the dietary supplement comprises between 10 mg and 3 g of each of the free-form amino acids per 16.5 g of dietary supplement. |
